Full View

DNAzyme-based lithium-selective imaging reveals higher lithium accumulation in bipolar disorder patient-derived neurons

CE McGhee, Z Yang, W Guo, Y Wu, M Lyu… - ACS Central …, 2021 - ACS Publications
Lithium has been a drug for bipolar disorders (BD) for over 70 years; however, its usage has
been limited by its narrow therapeutic window (between 0.6 and 1.2 mM). Understanding the …
被引用次数：37 相关文章

DNAzyme-Based Lithium-Selective Imaging Reveals Higher Lithium Accumulation in Bipolar Disorder Patient-Derived Neurons.

CE McGhee, Z Yang, W Guo, Y Wu, M Lyu… - ACS Central …, 2021 - europepmc.org
Lithium has been a drug for bipolar disorders (BD) for over 70 years; however, its usage has
been limited by its narrow therapeutic window (between 0.6 and 1.2 mM). Understanding the …

DNAzyme-Based Lithium-Selective Imaging Reveals Higher Lithium Accumulation in Bipolar Disorder Patient-Derived Neurons

CE McGhee, Z Yang, W Guo, Y Wu, M Lyu… - ACS Central …, 2021 - experts.illinois.edu
Lithium has been a drug for bipolar disorders (BD) for over 70 years; however, its usage has
been limited by its narrow therapeutic window (between 0.6 and 1.2 mM). Understanding the …

DNAzyme-Based Lithium-Selective Imaging Reveals Higher Lithium Accumulation in Bipolar Disorder Patient-Derived Neurons

CE McGhee, Z Yang, W Guo, Y Wu… - ACS central …, 2021 - pubmed.ncbi.nlm.nih.gov
Lithium has been a drug for bipolar disorders (BD) for over 70 years; however, its usage has
been limited by its narrow therapeutic window (between 0.6 and 1.2 mM). Understanding the …
[HTML] nih.gov

[HTML][HTML] DNAzyme-Based Lithium-Selective Imaging Reveals Higher Lithium Accumulation in Bipolar Disorder Patient-Derived Neurons

CE McGhee, Z Yang, W Guo, Y Wu, M Lyu… - ACS Central …, 2021 - ncbi.nlm.nih.gov
Lithium has been a drug for bipolar disorders (BD) for over 70 years; however, its usage has
been limited by its narrow therapeutic window (between 0.6 and 1.2 mM). Understanding the …